Survival Outcomes of Uterine Malignancies in Chinese Population
This study aims to determine survival outcomes (overall survival and progression-free survival) of primary uterine malignancies in China and relevant risk factors in a prospective cohort study.
Endometrial Neoplasms|Survival
OTHER: Follow-up for death and recurrence
Overall survival, Survival duration from diagnosis to death, 5 years|Progression-free survival, Survival duration from last treatment after remission to recurrence, 5 years
This study aims to determine survival outcomes (overall survival and progression-free survival) of primary uterine malignancies in China and relevant risk factors in a prospective cohort study.